Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2

Clinical and Experimental Metastasis

Volumn 29, Issue 5, 2012, Pages 409-417

  Bandapalli, Obul R ^a   MacHer Goeppinger, Stephan ^a   Schirmacher, Peter ^a   Brand, Karsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Colorectal liver metastasis; HSC; LS174T; PAK2; PDGFC

Indexed keywords

P21 ACTIVATED KINASE 2; PLATELET DERIVED GROWTH FACTOR C; LYMPHOKINE; MESSENGER RNA; P21 ACTIVATED KINASE; PAK2 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR C; SMALL INTERFERING RNA; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER INHIBITION; CARCINOMA CELL; CELL INVASION; COLON ADENOCARCINOMA; COLON METASTASIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER METASTASIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN SECRETION; STELLATE CELL; TUMOR GROWTH; TUMOR PROMOTION; ADENOCARCINOMA; ANIMAL; CELL PROLIFERATION; COLON TUMOR; DNA MICROARRAY; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; GENE EXPRESSION PROFILING; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HEPATIC STELLATE CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHOKINES; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P21-ACTIVATED KINASES; PARACRINE COMMUNICATION; PLATELET-DERIVED GROWTH FACTOR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84862319355     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9459-3     Document Type: Article

References (41)

1. Becker N, Wahrendorf J (1997) Krebsatlas der Bundesrepublik Deutschland. Springer, Berlin
2. Grem JL (1991) Current treatment approaches in colorectal cancer. Semin Oncol. 18(1 Suppl 1):17-26
3. Curley SA et al. (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metast Rev 23(1-2):165-182 (Pubitemid 38221602)
4. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375-379
5. Mueller MM, Fusenig NE (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4(11):839-849 (Pubitemid 39472951)
6. Bandapalli OR et al (2006) Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 118(1):74-89 (Pubitemid 41681582)
7. Bandapalli OR et al (2008) Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens. BMC Genomics 9:448
8. Brand K et al (2000) Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 60(20):5723-5730
9. Skobe M, Fusenig NE (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 95(3):1050-1055 (Pubitemid 28124910)
10. Forsberg K et al (1993) Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 90(2):393-397 (Pubitemid 23028868)
11. Shao ZM, Nguyen M, Barsky SH (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19(38):4337-4345
12. Tejada ML et al (2006) Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin Cancer Res 12(9):2676-2688
13. Gilbertson DG et al (2001) Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 276(29):27406-27414
14. Li X et al (2000) PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2(5):302-309
15. Campbell JS et al (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102(9):3389-3394 (Pubitemid 40328055)
16. Borkham-Kamphorst E et al (2008) Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest 88(10):1090-1100
17. Anderberg C et al (2009) Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res 69(1):369-378
18. Maass T et al (2010) Liver specific overexpression of plateletderived growth factor-β accelerates liver cancer development in chemically induced liver carcinogenesis. Int J Cancer 128:1259-1268
19. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10): 1276-1312 (Pubitemid 351717519)
20. Beeser A et al (2005) Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J Biol Chem 280(44):36609-36615 (Pubitemid 41587737)
21. Kumar R, Gururaj AE, Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6(6):459-471
22. Machuy N et al. (2007) c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles. J Mol Biol 370(4):620-632
23. Hsu RM et al (2010) Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration. Mol Biol Cell 21(2):287-301
24. Coniglio SJ, Zavarella S, Symons MH (2008) Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol 28(12):4162-4172 (Pubitemid 351812999)
25. Yi C et al (2008) Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. Cancer Res 68(19):7932-7937
26. Parola M, Marra F, Pinzani M (2008) Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med 29(1-2):58-66 (Pubitemid 351312216)
27. Bandapalli OR et al (2011) Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases. Anticancer Res 31(4):1215-1224
28. Wang Y, et al (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53(1):132-144
29. Xu L et al (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54(1):142-151 (Pubitemid 40007234)
30. Joyce JA (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7(6):513-520 (Pubitemid 40799245)
31. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4):429-447 (Pubitemid 36818244)
32. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432(7015): 332-337 (Pubitemid 39551661)
33. Rasanen K, Vaheri A (2010) Activation of fibroblasts in cancer stroma. Exp Cell Res 316(17):2713-2722
34. Kang N, Gores GJ, Shah VH (2011) Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54(2):707-713
35. Olaso E et al (1997) Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26(3):634-642 (Pubitemid 27392354)
36. Olaso E et al (2003) Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37(3):674-685 (Pubitemid 36258789)
37. Paku S, Kopper L, Nagy P (2005) Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer. Int J Cancer 115(6):893-902 (Pubitemid 40791829)
38. Faouzi S et al. (1999) Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol 30(2):275-284 (Pubitemid 29071192)
39. Mikula M et al (2006) Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol 209(2):560-567 (Pubitemid 44484647)
40. Amann T et al. (2009) Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100(4): 646-653
41. Rovida E et al (2008) ERK5 differentially regulates PDGFinduced proliferation and migration of hepatic stellate cells. J Hepatol 48(1):107-115 (Pubitemid 350191987)